Fidia S.p.A. (BIT:FDA)
| Market Cap | 4.29M +33.5% |
| Revenue (ttm) | 30.56M +74.3% |
| Net Income | 1.04M |
| EPS | 0.00 |
| Shares Out | 499.41M |
| PE Ratio | 2.87 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,515,248 |
| Open | 0.0088 |
| Previous Close | 0.0086 |
| Day's Range | 0.0084 - 0.0090 |
| 52-Week Range | 0.0030 - 0.4960 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 11, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions include... [Read more]
Financial Performance
Financial StatementsNews
BTI Responds to Senators on FDA ENDS Guidance
BTI Responds to Senators on FDA ENDS Guidance
Utz potato chips issued highest-level FDA recall over salmonella concerns
The Food and Drug Administration has elevated its recall of Utz potato chips, from the Dirty and Zapp’s brand, to its highest level over possible salmonella contamination.
Popular Potato Chips Face FDA's Most Serious Recall: What to Know
Utz Quality Foods voluntarily recalled select varieties of potato chips due to potential salmonella contamination in the seasoning powder.
FDA Alerts on Insulet (PODD) Device Safety Concerns
FDA Alerts on Insulet (PODD) Device Safety Concerns
Irish pharma company making ‘adulterated products’, US regulator claims
FDA inspected Genzyme facility on the outskirts of Waterford city and found ‘significant violations’
FIR filed against blood bank officials of Mumbai’s Sir JJ Mahanagar Blood Centre
FIR filed against JJ Mahanagar Blood Centre officials after FDA probe found alleged diversion of donated blood to a private bank; licence suspended, audit ordered.
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
(RTTNews) - The holiday-shortened week delivered no shortage of action for the biotech sector, with a mix of FDA, China, Canada, and EU approvals, acquisitions, and positive clinical readouts, alongsi...
Tenon Medical (TNON) Receives FDA Clearance for Catamaran SI Joint Fusion System
Tenon Medical (TNON) Receives FDA Clearance for Catamaran SI Joint Fusion System
FDA issues most serious recall alert for potato chip brands over salmonella risk
An estimated 650,000 bags of potato chips are affected as US agency upgraded recall of several popular brands The US Food and Drug Administration (FDA) has upgraded a recall of several popular brands ...
Ajanta Pharma receives US FDA's EIR for Paithan facility inspection
Ajanta Pharma Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located in Paith...
Telix Pharma Aligns With FDA To Advance ProstACT Phase 3 Trial Of TLX591-Tx In Prostate Cancer
(RTTNews) - Telix Pharmaceuticals Ltd (TLX), a commercial-stage biopharmaceutical company, announced the outcome of a Type B meeting with the Food and Drug Administration (FDA) to review the ProstACT ...
FDA Upgrades Zapp's and Dirty Brand Chip Recall to Highest Risk Level Over Salmonella Contamination Fears
The FDA has upgraded the recall of Zapp's and Dirty brand chips to Class I due to potential salmonella contamination from a California dairy supplier's dry milk powder.
Vertex Expands FDA Approval For CASGEVY In Children With Sickle Cell Disease And Beta Thalassemia
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) announced that the U.S. FDA has approved expanded use of CASGEVY for patients ages 2 years and older with sickle cell disease experiencing vaso-occlusive...
Vertex Pharmaceuticals (VRTX) Secures FDA Approval for CASGEVY in Young Patients
Vertex Pharmaceuticals (VRTX) Secures FDA Approval for CASGEVY in Young Patients
Vertex Pharmaceuticals (VRTX) Gains FDA Approval for Pediatric Gene Therapy
Vertex Pharmaceuticals (VRTX) Gains FDA Approval for Pediatric Gene Therapy
Recall of popular potato chips classified under FDA's highest risk level
The FDA classified the recall of these popular potato chips under its highest risk level due to potential salmonella contamination.
Cogent Submits NDA To FDA For Bezuclastinib In Treating Systemic Mastocytosis
(RTTNews) - Cogent Biosciences Inc. (COGT), a biotechnology company, on Tuesday announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for Bezuclastini...
Sarepta (SRPT) Maintains Sell Rating Despite FDA Developments
Sarepta (SRPT) Maintains Sell Rating Despite FDA Developments
Nicox Submits NDA To FDA For NCX 470 In Treating Ocular Hypertension; Response Expected In 2027
(RTTNews) - Nicox SA (ALCOX), an ophthalmology company, on Wednesday announced the submission of a new drug application (NDA) to the U.S. FDA, via its U.S. licensee Kowa, for NCX 470 in the treatment ...
Biotech Stocks Facing FDA Decision In July 2026
(RTTNews) - July is here, and the FDA is set to announce decisions on therapies for conditions ranging from breast cancer and IgA nephropathy to multiple myeloma, ADHD, and wet AMD.
Galderma Provides FDA Progress Update On RelabotulinumtoxinA Submission
(RTTNews) - Galderma (GDERF) announced it has received a Complete Response Letter (CRL) from the U.S. FDA regarding its Biologics License Application (BLA) for RelabotulinumtoxinA, a next-generation b...
Philip Morris International Gains First FDA MRTP Orders For ZYN Nicotine Pouches
(RTTNews) - Philip Morris International Inc. (PM) announced that the U.S. Food and Drug Administration (FDA) has issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouc...
Top Biotech Gainers: ABVX Soars On UC Trial Data, PMN Eyes Alzheimer's Catalyst, TRAX In Focus
(RTTNews) - Today's top gainers in the biotech space include Cuprina, which recently received FDA clearance for its maggot-based wound treatment; ABIVAX, following encouraging results from an ulcerati...
Mesoblast (MESO) Secures FDA Filing for Rexlemestrocel-L Review
Mesoblast (MESO) Secures FDA Filing for Rexlemestrocel-L Review
US FDA approves Orca Bio's blood cancer therapy
The U.S. Food and Drug Administration has approved Orca Bio's cell therapy for the treatment of certain blood cancers, the regulator said on Tuesday.